Skip to main content
. 2020 Jun 1;19:76. doi: 10.1186/s12904-020-00579-0

Table 1.

Characteristics

Variable No anticancer treatment last 30 days n = 174 Anticancer treatment given last 30 days n = 73 P value a
n % n %
Age (years) - median (min - max) 72 (18–93) 74 (40–91) NS
Length of stay (days) - median (min - max) 8 (0–84) 12 (0–68) 0.03
Gender NS
 Female 68 39% 28 38%
 Male 106 61% 45 62%
Hospital < 0.01
 District Hospital Lofoten 27 16% 6 8%
 District Hospital Vesterålen 47 27% 11 15%
 Central Hospital Bodø 100 57% 56 77%
Department NS
 Internal medicine 76 44% 44 60%
 Surgery 91 52% 25 34%
 Others 7 4% 4 6%
Primary malignancy 0.02
 Upper gastrointestinal 34 20% 5 7%
 Colorectal 27 15% 4 5%
 Lung 38 22% 21 29%
 Breast 7 4% 4 5%
 Gynaecological 5 3% 2 3%
 Urological 8 5% 6 8%
 Male genitalia 11 6% 4 5%
 Haematological and lymphoma 17 10% 22 30%
 Unknown origin 15 8% 2 3%
 Other b 12 7% 3 4%
Treatment intent < 0.001
 Palliative 135 78% 67 92%
 Curative 2 1% 3 4%
 Diagnostic 37 21% 3 4%
Anticancer treatment < 0.001
 Systemic treatment 64 37% 52 71%
 Radiotherapy 5 3% 14 19%
 Surgery 5 3% 7 10%
 No treatment 100 57% 0 0%
Specialist palliative care NS
  > 30 days before death 33 19% 11 15%
  < 30 days before death 32 18% 14 19%
 Not involved 109 63% 48 66%

aThe p value measures the difference between the two groups and was set to 0.05. NS not significant

bThe group consist of patients with cancer from head-neck, sarcoma, malignant melanoma, eye and CNS